Amyloidosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== Overview == | == Overview == | ||
There is no treatment for primary amyloidosis. | There is no treatment for primary amyloidosis. Since the disease is typically discovered at an advanced stage, the initial treatment is aimed at stopping and correcting [[organ failure]]. | ||
==Medical Therapy== | ==Medical Therapy== | ||
There is no treatment for primary amyloidosis. | There is no treatment for primary amyloidosis. | ||
Revision as of 16:45, 2 November 2012
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Amyloidosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Amyloidosis medical therapy |
|
Risk calculators and risk factors for Amyloidosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is no treatment for primary amyloidosis. Since the disease is typically discovered at an advanced stage, the initial treatment is aimed at stopping and correcting organ failure.
Medical Therapy
There is no treatment for primary amyloidosis.
- The initial target in the treatment of this disorder is to correct the organ failure, as the disease is discovered at an advanced stage.
- Nephrotic syndrome is treated using supportive therapy and diuretics.
- Renal failure is treated with dialysis
- Heart failure is treated using diuretics
- Gastrointestinal and nerve involvement are treated symptomatically.
Treatment options with limited success include melphalan and prednisone, and colchicine.